Thanks to @medpagetoday and @genevievefri for allowing me to share my thoughts on outpatient management of AKI-D. medpagetoday.com/opinion/sec…

The draft of the KDIGO 2026 AKI/AKD Guideline is now available for public review through April 27, 2026. Download the guideline and submit comments via the feedback form on the guideline website: kdigo.org/guidelines/acute-k… This update to the 2012 guideline introduces a unified framework across AKI and AKD, with advances in diagnosis, prevention, and management, including updated recommendations on biomarkers, kidney replacement therapy, and follow-up care. Recommendations were developed by an international Work Group, including patient representatives, using GRADE methodology. KDIGO welcomes feedback from the global kidney community. Reviewers may focus on sections most relevant to their expertise, and contributors may be acknowledged in the final publication. #AKI #AKD

Check out our ideas on how to fix AKI-D policy problems: (1) no incentives to monitor for recovery, (2) no incentives to treat AKI-D differently than ESKD, (3) no AKI-D quality metrics, and (4) no transplant wait-time accrual until ESKD. https:// bit.ly/4dCvbhq

This Perspective by @NephroNinja and @eugelin06 describes both the financial and non-financial implications of the AKI-D to ESKD status transition. Implications of AKI-D Versus ESKD Status bit.ly/4dCvbhq @UCSFNephrology @KeckKidneys

Does the % reduction in albuminuria after starting SGLT2i inform the magnitude of benefit? Do people with 80% reduction see more stabilization of eGFR than people with 30% reduction? @askrenal

Glad I wasn't on jeopardy tonight. IgA nephropathy causes swelling in this organ...(kidneys was the answer). Microscopic swelling I guess, from glomerulonephritis? 🧐

Photo of me when I read “creatinine and kidney function better after dialysis yesterday”

Anyone have a guess what these are? 🤔🤨🧐 #askrenal @askrena

The CKD awareness publication in JAMA Cardiology is really the furthest thing from novel. If anything, I am surprised that we continue to talk about this topic. The much more interesting question is how many people with eGFR-defined CKD would benefit from knowing that they have a disease that could (but usually will not) end in kidney failure.

The world only eats 1.3 billion pigs per year?! That seems low to me (< 1 pig per 5 people, right?). Maybe I underestimate how much meat each pig produces or overestimate how popular pork is...🤔 #KidneyWk

More dialysis ≠ better in AKI-D. Trials (STARRT-AKI, ATN, LIBERATE-D, FHN) show more sessions/accelerated RRT → ↑ intradialytic hypotension and worse renal recovery (e.g., ↑90-day dialysis dependence in STARRT-AKI). Watch for recovery and wean/space ASAP. #KidneyWk

Is it odd that ASN, AHA, and AASLD meetings are all happening this weekend? Seems like there must be some people prevented from attending multiple meetings. On the other hand, it's a great weekend for med Twitter!

I would love to know if Finerenone works in ascites, at what dose and if less risk lf hyperkalemia Dr Fakhoury took a look. #tlm25

Superstar fellow Dr. Ayeesha Kattubadi spreading some knowledge! @UCSFNephrology #KidneyWk

Superstar fellow Dr. Divya Ravi teaching me steroid metabolism! @UCSFNephrology #KidneyWk

📖 A Conservative Dialysis Strategy and Kidney Function Recovery in Dialysis-Requiring Acute Kidney Injury: The LIBERation from AcuTE Dialysis (LIBERATE-D) Randomized Clinical Trial ➡️ Presented today at #KidneyWk ➡️ Free to read online: ja.ma/48Ngo0W

Super important findings - one of the most vexing clinical problems in nephrology: how to support kidney recovery from AKI-D Looks like a conservative approach to HD may be best - we need this to spark the larger trial! #KidneyWk

#KidneyWk AKI-D positive trial! Dr. Hsu reporting our LIBERATE-D trial at the late breaking clinical trials session, with simultaneous publication in JAMA: jamanetwork.com/journals/jam…

Love the decision to add high impact clinical trial sessions to the plenaries! ❤️❤️❤️ #KidneyWk

Competency of Anthem medical directors or defective AI? Here is denial of a fistula declot: “Rationale: we cannot approve a test (diagnostic angiography of the dialysis circuit with or without intervention) related to your dialysis. This is because it is not medically necessary”

👏 Congratulations to Ron Wald, MDCM, MPH, FRCPC (@DrRonWald), recipient of the 2026 J. Michael Lazarus Distinguished Award! Learn more ➡️ bit.ly/3KbhusW We look forward to celebrating at SCM26 #NKFClinicals. Stay tuned for registration opening October.